CBA

1.53%

$134.77 commonwealth bank of australia.

Well that DRP info is interesting. Thanks for pulling that...

First 4 Last

Ricko5

82 Posts.

09/08/23

20:39

Post #: 69255930

Originally posted by hudathunkit: ↑
Re DRP - some folks have wondered if it was better to join the DRP from a value standpoint. For people like myself, who are only receiving 'unviable' parcels every 6 months, it is a way to grow your holding without having to pay brokerage, so, there's that.

For the heck of it, I just checked some historical prices against the DRP price over the last decade.
(some figures are rounded to the cent)

Just for info & DYOR & not intended as adz.

Half year ended
Dividend per share (AUD) Payment date DRP price (AUD) SP Low during Dividend Payment Week Difference
1 30/06/2023 $2.40 28/09/2023 n/a n/a
2 31/12/2022 $2.10 30/03/2023 $97.37 $94.85 $2.52
3 30/06/2022 $2.10 29/09/2022 $96.44 $90.26 $6.18
4 31/12/2021 $1.75 30/03/2022 $97.95 $104.52 -$6.57
5 30/06/2021 $2.00 29/09/2021 $101.00 $99.62 $1.38
6 31/12/2020 $1.50 30/03/2021 $85.25 $85.13 $0.12
7 30/06/2020 $0.98 30/09/2020 $68.53 $63.56 $4.97
8 31/12/2019 $2.00 31/03/2020 $73.37 $57.85 $15.52
9 30/06/2019 $2.31 26/09/2019 $78.61 $80.88 -$2.27
10 31/12/2018 $2.00 28/03/2019 $73.21 $70.20 $3.01
11 30/06/2018 $2.31 28/09/2018 $72.05 $71.68 $0.37
12 31/12/2017 $2.00 28/03/2018 $75.38 $71.71 $3.67
13 30/06/2017 $2.30 29/09/2017 $75.73 $74.40 $1.33
14 31/12/2016 $1.99 4/04/2017 $83.21 $84.09 -$0.88
15 30/06/2016 $2.22 29/09/2016 $72.95 $72.20 $0.75
16 31/12/2015 $1.98 31/03/2016 $72.68 $72.60 $0.09
17 30/06/2015 $2.22 1/10/2015 $74.75 $70.15 $4.60
18 31/12/2014 $1.98 2/04/2015 $91.26 $92.09 -$0.83
19 30/06/2014 $2.18 2/10/2014 $80.39 $73.71 $6.68
20 31/12/2013 $1.83 3/04/2014 $75.26 $76.18 -$0.92
21 30/06/2013 $2.00 3/10/2013 $73.42 $70.77 $2.65
Expand
Well that DRP info is interesting. Thanks for pulling that together. So if I'm reading it correctly, over the years, the DRP is on average higher than the SP during the dividend week. Good to know

CBA Price at posting: $104.85 Sentiment: Hold Disclosure: Held

1 Upvote

0 Great analysis

Top Stories

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

There are more pages in this discussion • 3 more messages in this thread...

First 4 Last

Add CBA (ASX) to my watchlist

(20min delay)
Last $134.77		Change 2.030(1.53%)		Mkt cap ! $225.5B

Open	High	Low	Value	Volume
$133.82	$135.08	$133.13	$125.7M	934.9K

Buyers (Bids)

No.	Vol.	Price($)
1	159	$134.73

Sellers (Offers)

Price($)	Vol.	No.
$134.77	506	1

View Market Depth

No.	Vol.	Price($)
1	159	134.730
1	2	134.700
1	4	134.680
1	37	134.520
2	2784	134.480

Price($)	Vol.	No.
134.770	506	1
134.800	360	1
134.820	2286	1
134.850	360	1
134.870	2268	1

Last trade - 16.10pm 07/10/2024 (20 minute delay)

CBA (ASX) Chart

Well that DRP info is interesting. Thanks for pulling that...

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

	Half year ended	Dividend per share (AUD)	Payment date	DRP price (AUD)	SP Low during Dividend Payment Week	Difference
1	30/06/2023	$2.40	28/09/2023	n/a	n/a
2	31/12/2022	$2.10	30/03/2023	$97.37	$94.85	$2.52
3	30/06/2022	$2.10	29/09/2022	$96.44	$90.26	$6.18
4	31/12/2021	$1.75	30/03/2022	$97.95	$104.52	-$6.57
5	30/06/2021	$2.00	29/09/2021	$101.00	$99.62	$1.38
6	31/12/2020	$1.50	30/03/2021	$85.25	$85.13	$0.12
7	30/06/2020	$0.98	30/09/2020	$68.53	$63.56	$4.97
8	31/12/2019	$2.00	31/03/2020	$73.37	$57.85	$15.52
9	30/06/2019	$2.31	26/09/2019	$78.61	$80.88	-$2.27
10	31/12/2018	$2.00	28/03/2019	$73.21	$70.20	$3.01
11	30/06/2018	$2.31	28/09/2018	$72.05	$71.68	$0.37
12	31/12/2017	$2.00	28/03/2018	$75.38	$71.71	$3.67
13	30/06/2017	$2.30	29/09/2017	$75.73	$74.40	$1.33
14	31/12/2016	$1.99	4/04/2017	$83.21	$84.09	-$0.88
15	30/06/2016	$2.22	29/09/2016	$72.95	$72.20	$0.75
16	31/12/2015	$1.98	31/03/2016	$72.68	$72.60	$0.09
17	30/06/2015	$2.22	1/10/2015	$74.75	$70.15	$4.60
18	31/12/2014	$1.98	2/04/2015	$91.26	$92.09	-$0.83
19	30/06/2014	$2.18	2/10/2014	$80.39	$73.71	$6.68
20	31/12/2013	$1.83	3/04/2014	$75.26	$76.18	-$0.92
21	30/06/2013	$2.00	3/10/2013	$73.42	$70.77	$2.65

Well that DRP info is interesting. Thanks for pulling that...

Top Stories

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News